MIRM logo

Mirum Pharmaceuticals (MIRM) Depreciation and amortization

annual D&A:

$23.63M+$12.80M(+118.20%)
December 31, 2024

Summary

  • As of today (June 1, 2025), MIRM annual depreciation & amortization is $23.63 million, with the most recent change of +$12.80 million (+118.20%) on December 31, 2024.
  • During the last 3 years, MIRM annual D&A has risen by +$23.03 million (+3871.26%).
  • MIRM annual D&A is now at all-time high.

Performance

MIRM Depreciation and amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMIRMincome statement metrics

quarterly D&A:

$6.05M-$4000.00(-0.07%)
March 31, 2025

Summary

  • As of today (June 1, 2025), MIRM quarterly depreciation & amortization is $6.05 million, with the most recent change of -$4000.00 (-0.07%) on March 31, 2025.
  • Over the past year, MIRM quarterly D&A has increased by +$388.00 thousand (+6.85%).
  • MIRM quarterly D&A is now -0.07% below its all-time high of $6.06 million, reached on December 31, 2024.

Performance

MIRM quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMIRMincome statement metrics

TTM D&A:

$24.02M+$388.00K(+1.64%)
March 31, 2025

Summary

  • As of today (June 1, 2025), MIRM TTM depreciation & amortization is $24.02 million, with the most recent change of +$388.00 thousand (+1.64%) on March 31, 2025.
  • Over the past year, MIRM TTM D&A has increased by +$8.86 million (+58.47%).
  • MIRM TTM D&A is now at all-time high.

Performance

MIRM TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMIRMincome statement metrics

MIRM Depreciation and amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+118.2%+6.8%+58.5%
3 y3 years+3871.3%+1266.1%+2715.6%
5 y5 years+7192.9%+3779.5%+5201.8%

MIRM Depreciation and amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+3871.3%-0.1%+1266.1%at high+2715.6%
5 y5-yearat high+7192.9%-0.1%>+9999.0%at high+5201.8%
alltimeall timeat high+7192.9%-0.1%>+9999.0%at high>+9999.0%

MIRM Depreciation and amortization History

DateAnnualQuarterlyTTM
Mar 2025
-
$6.05M(-0.1%)
$24.02M(+1.6%)
Dec 2024
$23.63M(+118.2%)
$6.06M(+0.0%)
$23.63M(+2.4%)
Sep 2024
-
$6.05M(+3.4%)
$23.07M(+17.2%)
Jun 2024
-
$5.85M(+3.4%)
$19.67M(+29.8%)
Mar 2024
-
$5.66M(+3.1%)
$15.16M(+40.0%)
Dec 2023
$10.83M(+234.4%)
$5.49M(+106.4%)
$10.83M(+65.7%)
Sep 2023
-
$2.66M(+99.3%)
$6.54M(+31.5%)
Jun 2023
-
$1.34M(-0.1%)
$4.97M(+20.3%)
Mar 2023
-
$1.34M(+11.3%)
$4.13M(+27.6%)
Dec 2022
$3.24M
$1.20M(+9.6%)
$3.24M(+54.6%)
Sep 2022
-
$1.10M(+120.1%)
$2.09M(+78.1%)
Jun 2022
-
$498.00K(+12.4%)
$1.18M(+37.9%)
DateAnnualQuarterlyTTM
Mar 2022
-
$443.00K(+677.2%)
$853.00K(+43.4%)
Dec 2021
$595.00K(-4.5%)
$57.00K(-68.0%)
$595.00K(-15.4%)
Sep 2021
-
$178.00K(+1.7%)
$703.00K(+3.4%)
Jun 2021
-
$175.00K(-5.4%)
$680.00K(+4.3%)
Mar 2021
-
$185.00K(+12.1%)
$652.00K(+4.7%)
Dec 2020
$623.00K(+92.3%)
$165.00K(+6.5%)
$623.00K(+7.8%)
Sep 2020
-
$155.00K(+5.4%)
$578.00K(+12.9%)
Jun 2020
-
$147.00K(-5.8%)
$512.00K(+13.0%)
Mar 2020
-
$156.00K(+30.0%)
$453.00K(+39.8%)
Dec 2019
$324.00K
$120.00K(+34.8%)
$324.00K(+58.8%)
Sep 2019
-
$89.00K(+1.1%)
$204.00K(+77.4%)
Jun 2019
-
$88.00K(+225.9%)
$115.00K(+325.9%)
Mar 2019
-
$27.00K
$27.00K

FAQ

  • What is Mirum Pharmaceuticals annual depreciation & amortization?
  • What is the all time high annual D&A for Mirum Pharmaceuticals?
  • What is Mirum Pharmaceuticals annual D&A year-on-year change?
  • What is Mirum Pharmaceuticals quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Mirum Pharmaceuticals?
  • What is Mirum Pharmaceuticals quarterly D&A year-on-year change?
  • What is Mirum Pharmaceuticals TTM depreciation & amortization?
  • What is the all time high TTM D&A for Mirum Pharmaceuticals?
  • What is Mirum Pharmaceuticals TTM D&A year-on-year change?

What is Mirum Pharmaceuticals annual depreciation & amortization?

The current annual D&A of MIRM is $23.63M

What is the all time high annual D&A for Mirum Pharmaceuticals?

Mirum Pharmaceuticals all-time high annual depreciation & amortization is $23.63M

What is Mirum Pharmaceuticals annual D&A year-on-year change?

Over the past year, MIRM annual depreciation & amortization has changed by +$12.80M (+118.20%)

What is Mirum Pharmaceuticals quarterly depreciation & amortization?

The current quarterly D&A of MIRM is $6.05M

What is the all time high quarterly D&A for Mirum Pharmaceuticals?

Mirum Pharmaceuticals all-time high quarterly depreciation & amortization is $6.06M

What is Mirum Pharmaceuticals quarterly D&A year-on-year change?

Over the past year, MIRM quarterly depreciation & amortization has changed by +$388.00K (+6.85%)

What is Mirum Pharmaceuticals TTM depreciation & amortization?

The current TTM D&A of MIRM is $24.02M

What is the all time high TTM D&A for Mirum Pharmaceuticals?

Mirum Pharmaceuticals all-time high TTM depreciation & amortization is $24.02M

What is Mirum Pharmaceuticals TTM D&A year-on-year change?

Over the past year, MIRM TTM depreciation & amortization has changed by +$8.86M (+58.47%)
On this page